Table 1.
Demographic and clinical features of patients with COVID
| All patients (n = 100) | IRS system | P | Post-hoc test* | |||
|---|---|---|---|---|---|---|
| Mild (n = 29) |
Moderate (n = 12) |
Severe (n = 59) |
||||
| Age, years | 55 ± 13 | 49 ± 13 | 54 ± 13 | 57 ± 12 | 0.030 |
a: 0.999 b: 0.026 c: 0.999 |
| Male, n (%) | 71 (71) | 20 (69) | 8 (67) | 43 (73) | 0.874 | |
| BMI, kg/m2 | 28.6 ± 4.8 | 27.9 ± 3.6 | 29.3 ± 5.0 | 28.8 ± 5.3 | 0.611 | |
| Hypertension, n (%) | 47 (47) | 11 (38) | 7 (58) | 29 (49) | 0.430 | |
| Diabetes, n (%) | 37 (37) | 8 (28) | 3 (25) | 26 (44) | 0.211 | |
| Dyslipidemia, n (%) | 17 (17) | 5 (17) | 1 (8) | 11 (19) | 0.686 | |
| Smoking, n (%) | 21 (21) | 6 (21) | 3 (25) | 12 (20) | 0.935 | |
| Cancer, n (%) | 2 (2) | 0 | 0 | 2 (3) | 0.492 | |
| Previous MI, n (%) | 10 (10) | 2 (7) | 1 (8) | 7 (12) | 0.750 | |
| CHD, n (%) | 5 (5) | 3 (10) | 0 | 2 (3) | 0.259 | |
| CKD, n (%) | 13 (13) | 2 (7) | 0 | 11 (19) | 0.110 | |
| Organ transplant, n (%) | 2 (2) | 1 (3) | 0 | 1 (2) | 0.463 | |
| CCI, median (IQR) | 2 (1–3) | 1 (0–3) | 1 (0.7–3.2) | 3 (1–3.5) | 0.032 |
a: 0.999 b: 0.034 c: 0.640 |
Data are presented as mean ± standard deviation unless otherwise specified. Significant P values are in bold
Definitions: IRS system, Inflammation-based risk scoring system; BMI, body mass index; MI, myocardial infarction; CHD, chronic heart disease; CKD, chronic kidney disease; CCI, Charlson Comorbidity Index; IQR, interquartile range
* a: Mild versus Moderate; b: Mild versus Severe; c: Moderate versus Severe